Prevalence and Characterization of Pain in RASopathies
NCT06355622 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2025-03-21
Summary
RASopathies are a group of syndromes caused by variants in genes belonging to the RAS/MAPK pathway. Pain is a neglected topic in RASopathies but it is frequently complained by affected individuals.
Conditions
- RASopathy
- Costello Syndrome
- Cardio-Facio-Cutaneous Syndrome
- Noonan Syndrome
Interventions
- DIAGNOSTIC_TEST
-
Characterization of pain
Standardized scales and questionnaires to detect and characterize pain, blood sample for pain biomarkers, neurophysiological tests
Sponsors & Collaborators
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
lead OTHER
Principal Investigators
-
Chiara Leoni, MD, PhD · Fondazione Policlinico A. Gemelli, IRCCS
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-01-27
- Primary Completion
- 2024-01-30
- Completion
- 2025-06-30
Countries
- Italy
Study Locations
More Related Trials
-
Pathogenic Mechanisms Involved in the Initiation and Progression of Systemic Sclerosis
NCT07015060 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Assessment of the Rosacea Prevalence in the General Population
NCT02292797 ·Status: COMPLETED
-
Fibroblast Line Evaluation for COL5A eXpression and Thoracic Aortic Aneurysms: in Vitro Characterization of Cutaneous Fibroblasts in Adult Patients
NCT07282717 ·Status: NOT_YET_RECRUITING
-
Skin Denervation in Systemic Lupus Erythematosus
NCT00155532 ·Status: COMPLETED ·Phase: PHASE1
-
Familial Systemic Scleroderma
NCT07343115 ·Status: RECRUITING
-
DERMATOMICS: Identifying Regulators of Skin Homeostasis
NCT06894654 ·Status: RECRUITING
-
Pathophysiology Analysis of "Costello Syndrome" on Cellular Models
NCT02812511 ·Status: COMPLETED ·Phase: NA
-
Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases
NCT05732987 ·Status: RECRUITING
-
Development and Prevention of Severe Heart Disease in Systemic Sclerosis
NCT01829126 ·Status: UNKNOWN
-
Study to Test Genetic Alterations Among Different Dermoscopic Types of Melanocytic Nevi.
NCT00422448 ·Status: COMPLETED ·Phase: NA
-
Lenalidomide in the Treatment of Refractory Cutaneous Dermatomyositis
NCT05488327 ·Status: UNKNOWN ·Phase: NA
-
Diagnostic Role of Renal Biopsy in Patients With Fabry Disease
NCT06801288 ·Status: COMPLETED
-
Western Sweden Systemic Sclerosis Project
NCT07345052 ·Status: RECRUITING
-
High Dose Intravenous N-Acetylcysteine Versus Iloprost for Early, Rapidly Progressive Diffuse Systemic Sclerosis
NCT00428883 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Thalidomide for Decreasing Collagen Biosynthesis in People With Progressive Systemic Sclerosis
NCT00418132 ·Status: TERMINATED ·Phase: PHASE1
-
Optical Coherence Tomography Imaging in Systemic Sclerosis
NCT04532151 ·Status: COMPLETED ·Phase: NA
-
Personalized Therapy of Patients Suffering From Rare Genodermatoses
NCT05680974 ·Status: UNKNOWN
-
Early Screening Markers of Herpes Zoster Neuralgia
NCT07038707 ·Status: NOT_YET_RECRUITING
-
A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy
NCT00936546 ·Status: COMPLETED ·Phase: PHASE2
-
Early Detection and Follow-Up of Patients With Fabry's Disease
NCT04847713 ·Status: UNKNOWN
-
Investigation of Biomarkers in Susac Syndrome
NCT01273792 ·Status: UNKNOWN
-
Clinical and Paraclinical Characteristics of the Systemic Scleroderma Cohort According to the Criteria ACR 2013 and the History of Professional Exposure or of Agricultural Environment
NCT03262922 ·Status: COMPLETED
-
Early Diagnosis of Pulmonary Hypertension in Patients With Inflammatory Rheumatic Connective Tissue Diseases
NCT01387035 ·Status: RECRUITING
-
Cyclophosphamide and rATG With Hematopoietic Stem Cell Support in Systemic Scleroderma
NCT00278525 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Manifestations of Systemic Sclerosis
NCT02371005 ·Status: TERMINATED ·Phase: NA